UniProt ID | PIGA_HUMAN | |
---|---|---|
UniProt AC | P37287 | |
Protein Name | Phosphatidylinositol N-acetylglucosaminyltransferase subunit A | |
Gene Name | PIGA | |
Organism | Homo sapiens (Human). | |
Sequence Length | 484 | |
Subcellular Localization |
Endoplasmic reticulum membrane Single-pass membrane protein. |
|
Protein Description | Necessary for the synthesis of N-acetylglucosaminyl-phosphatidylinositol, the very early intermediate in GPI-anchor biosynthesis.. | |
Protein Sequence | MACRGGAGNGHRASATLSRVSPGSLYTCRTRTHNICMVSDFFYPNMGGVESHIYQLSQCLIERGHKVIIVTHAYGNRKGIRYLTSGLKVYYLPLKVMYNQSTATTLFHSLPLLRYIFVRERVTIIHSHSSFSAMAHDALFHAKTMGLQTVFTDHSLFGFADVSSVLTNKLLTVSLCDTNHIICVSYTSKENTVLRAALNPEIVSVIPNAVDPTDFTPDPFRRHDSITIVVVSRLVYRKGIDLLSGIIPELCQKYPDLNFIIGGEGPKRIILEEVRERYQLHDRVRLLGALEHKDVRNVLVQGHIFLNTSLTEAFCMAIVEAASCGLQVVSTRVGGIPEVLPENLIILCEPSVKSLCEGLEKAIFQLKSGTLPAPENIHNIVKTFYTWRNVAERTEKVYDRVSVEAVLPMDKRLDRLISHCGPVTGYIFALLAVFNFLFLIFLRWMTPDSIIDVAIDATGPRGAWTNNYSHSKRGGENNEISETR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Methylation | ----MACRGGAGNGH ----CCCCCCCCCCC | 36.72 | 115487533 | |
21 | Phosphorylation | SATLSRVSPGSLYTC CEEECCCCCCCEEEE | 23.56 | 21712546 | |
24 | Phosphorylation | LSRVSPGSLYTCRTR ECCCCCCCEEEEECC | 22.91 | 26993267 | |
26 | Phosphorylation | RVSPGSLYTCRTRTH CCCCCCEEEEECCCC | 12.90 | 26552605 | |
27 | Phosphorylation | VSPGSLYTCRTRTHN CCCCCEEEEECCCCE | 10.78 | 26552605 | |
32 | Phosphorylation | LYTCRTRTHNICMVS EEEEECCCCEEEEEE | 20.75 | - | |
85 | Phosphorylation | KGIRYLTSGLKVYYL CCHHHHCCCCEEEEE | 39.26 | 26503514 | |
90 | Phosphorylation | LTSGLKVYYLPLKVM HCCCCEEEEEECEEE | 9.56 | - | |
91 | Phosphorylation | TSGLKVYYLPLKVMY CCCCEEEEEECEEEC | 12.58 | - | |
98 | Phosphorylation | YLPLKVMYNQSTATT EEECEEECCCCHHHH | 17.03 | - | |
105 | Phosphorylation | YNQSTATTLFHSLPL CCCCHHHHHHHHHHH | 25.59 | 22210691 | |
109 | Phosphorylation | TATTLFHSLPLLRYI HHHHHHHHHHHHHHH | 25.09 | 22210691 | |
254 | Phosphorylation | IPELCQKYPDLNFII HHHHHHHCCCCCEEE | 3.98 | 26074081 | |
293 | Ubiquitination | LLGALEHKDVRNVLV HHHHHCCCCHHHHEE | 48.85 | - | |
354 | Phosphorylation | LCEPSVKSLCEGLEK EECHHHHHHHHHHHH | 35.78 | 27251275 | |
361 | Ubiquitination | SLCEGLEKAIFQLKS HHHHHHHHHHHHHHC | 52.40 | - | |
367 | Ubiquitination | EKAIFQLKSGTLPAP HHHHHHHHCCCCCCC | 35.74 | - | |
385 | Phosphorylation | HNIVKTFYTWRNVAE HHHHHHHHHHHHHHH | 15.60 | - | |
396 | Acetylation | NVAERTEKVYDRVSV HHHHHHCHHHHCCCE | 45.54 | 88435 | |
402 | Phosphorylation | EKVYDRVSVEAVLPM CHHHHCCCEEEECCC | 18.35 | 26471730 | |
467 | N-linked_Glycosylation | PRGAWTNNYSHSKRG CCCCCCCCCCCCCCC | 32.10 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PIGA_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PIGA_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PIGA_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TRAF1_HUMAN | TRAF1 | physical | 28514442 | |
TRFL_HUMAN | LTF | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H01053 | Paroxysmal nocturnal hemoglobinuria (PNH) | |||||
OMIM Disease | ||||||
300818 | Paroxysmal nocturnal hemoglobinuria 1 (PNH1) | |||||
300868 | Multiple congenital anomalies-hypotonia-seizures syndrome 2 (MCAHS2) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21, AND MASSSPECTROMETRY. |